Literature DB >> 6145474

Is Ro 03-7894 an irreversible antagonist at beta-adrenoceptor sites?

E Krstew, G A McPherson, E Malta, P Molenaar, C Raper.   

Abstract

Ro 03-7894 (0.6 mM) produced a non-parallel shift to the right of dose-response curves to (-)-isoprenaline in K+ depolarized uterine preparations from the guinea-pig. The displacement of the curves was readily reversed by washing. A rightward shift of similar magnitude was also produced by Ro 03-7894 in transmurally stimulated ileal preparations. The relaxant effects of fenoterol in carbachol-contracted guinea-pig tracheal preparations (in the presence of 2 microM atenolol) were not altered by 0.6 mM Ro 03-7894. In the three tissues there was no evidence of a reduction in the maximal inhibitory response to the agonists. In uterine and tracheal preparations, Ro 03-7894 (0.6 mM) depressed contractile responses to exogenous calcium. The depression of responses was enhanced after washout of Ro 03-7894 for 80 min. Contractile responses of ileal preparations to transmural stimulation were also depressed by Ro 03-7894. Concentration-effect curves for the positive inotropic effects of (-)-isoprenaline in guinea-pig left atrial preparations were markedly shifted to the right and the maximum response depressed by 0.6 mM Ro 03-7894. Although the rightward shift of the curves was fully reversed during the 120 min washout period, the maximal responses remained depressed. In similar experiments, Ro 03-7894 produced a washout-resistant depression of inotropic responses to histamine and calcium. The results of radioligand binding studies in left atria using (-)-[125I]-iodocyanopindolol indicated that, when compared to the untreated atria, there was no reduction in the maximal density of binding sites 120 min after washout of 0.6 mM Ro 03-7894. 5 On the basis of the present results it is concluded that Ro 03-7894 induces a non-specific depressant effect on smooth and cardiac muscle preparations during exposure to the drug. This depressant effect persists following washout of the drug. There is no evidence for an irreversible effect of Ro 03-7894 at beta-adrenoceptor sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145474      PMCID: PMC1987030          DOI: 10.1111/j.1476-5381.1984.tb10786.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines.

Authors:  E J Mylecharane; C Raper
Journal:  Eur J Pharmacol       Date:  1971-09       Impact factor: 4.432

2.  Comparison of guinea pig uterine and rat vas deferens preparations for assessment of beta 2-adrenoceptor-mediated activity.

Authors:  E Krstew; E Malta; C Raper
Journal:  J Pharmacol Methods       Date:  1982-12

3.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

4.  Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes.

Authors:  D Hoyer; G Engel; R Berthold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

5.  Influence of N-alkyl substitution on antagonism at 1 - and 2 -receptor sites.

Authors:  E J Mylecharane; C Raper
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

6.  Irreversible beta-adrenoceptor blockade of atrial rate and tension responses.

Authors:  C D Nicholson; K J Broadley
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

7.  Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques.

Authors:  A Rankin; K J Broadley
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

8.  Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversible beta-adrenoceptor antagonist.

Authors:  K J Broadley; C D Nicholson
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

9.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

10.  Responses mediated via beta 1, but not beta 2-adrenoceptors, exhibit hypothermia-induced supersensitivity.

Authors:  R G Williams; K J Broadley
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

View more
  5 in total

1.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. 1985.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

3.  The determination of receptor constants for histamine H2-agonists in the guinea-pig isolated right atrium using an irreversible H2-antagonist.

Authors:  T J Rising; A Steward
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

4.  Cardiac postjunctional supersensitivity to beta-agonists after chronic chemical sympathectomy with 6-hydroxydopamine.

Authors:  R G Chess-Williams; P F Grassby; W Culling; W Penny; K J Broadley; D J Sheridan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

5.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.